Mark W. Richards
Leeds, ENG LS29JT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Gluebodies Offer a Route To Improve Crystal Reliability and Diversity through Transferable Nanobody Mutations That Introduce Constitutive Close Contacts.
Journal: ACS central science
Published: May 23, 2025
An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes.
Journal: Cancer letters
Published: March 28, 2025
Structural characterization and inhibition of the interaction between ch-TOG and TACC3.
Journal: The Journal of cell biology
Published: July 01, 2024
Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy.
Journal: The Biochemical journal
Published: May 22, 2024
A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation.
Journal: Open biology
Published: March 19, 2024
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase.
Journal: RSC medicinal chemistry
Published: March 04, 2020
Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase.
Journal: ACS medicinal chemistry letters
Published: December 17, 2019
EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7.
Journal: Journal of cell science
Published: December 02, 2019
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.
Journal: The Journal of clinical investigation
Published: October 08, 2019
Last Updated: 09/26/2026